In contemporary oncology, several cautionary measures contribute to reduce the risk of on-treatment ventricular dysfunction and heart failure (HF). These measures include baseline evaluation of patient’s cardiovascular characteristics, optimal treatment of comorbidities, and avoidance of unnecessary high cumulative doses of anthracyclines
Heart Failure in Long-Term Survivors of Childhood or Adolescent Cancers
Minotti, Giorgio
2021-01-01
Abstract
In contemporary oncology, several cautionary measures contribute to reduce the risk of on-treatment ventricular dysfunction and heart failure (HF). These measures include baseline evaluation of patient’s cardiovascular characteristics, optimal treatment of comorbidities, and avoidance of unnecessary high cumulative doses of anthracyclinesFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
20.500.12610-79226.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
461.67 kB
Formato
Adobe PDF
|
461.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
